Orient Pharma Co Ltd operates in the Pharmaceutical preparations sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Orient Pharma Co Ltd with three other
companies in this sector in Taiwan:
General Biological Corporation
sales of 184.55 million Taiwanese Dollars [US$6.14 million]
of which 56%
was Testing Drug-Sales),
UBI Pharma Inc
(357.74 million Taiwanese Dollars [US$11.90 million]
of which 100%
was Single Segment), and
Bora Pharmaceuticals Co Ltd
(283.26 million Taiwanese Dollars [US$9.42 million]
Orient Pharma Co Ltd reported sales of 274.38 million Taiwanese Dollars (US$9.13 million)
December of 2016.
increase of 79.3%
versus 2015, when the company's sales were 152.99 million Taiwanese Dollars.
Sales of Global Business saw an increase
that was more than double the company's growth rate: sales were up
471.4% in 2016, from
18.45 million Taiwanese Dollars to 105.39 million Taiwanese Dollars.